Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Amitiza, RU-0211, SPI-0211, Lubiprostone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 577,102Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Kirby Eades Gale Baker

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Kirby Eades Gale Baker

    LUBIPROSTONE
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Kirby Eades Gale Baker

    Country
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Patent Expiration Date : 2020-10-13

    Date Granted : 2009-02-10

    LUBIPROSTONE

    Brand Name : AMITIZA

    Patent Number : 2385732

    Filing Date : 2000-10-13

    Strength per Unit : 24 mcg

    Dosage Form : CAPSULE

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2020-10-13

    Date Granted : 2009-02-10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Kirby Eades Gale Baker

    LUBIPROSTONE
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Kirby Eades Gale Baker

    Country
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Patent Expiration Date : 2021-09-04

    Date Granted : 2010-11-30

    LUBIPROSTONE

    Brand Name : AMITIZA

    Patent Number : 2419741

    Filing Date : 2001-09-04

    Strength per Unit : 24 mcg

    Dosage Form : CAPSULE

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2021-09-04

    Date Granted : 2010-11-30

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Kirby Eades Gale Baker

    LUBIPROSTONE
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Kirby Eades Gale Baker

    Country
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Patent Expiration Date : 2022-11-14

    Date Granted : 2011-12-13

    LUBIPROSTONE

    Brand Name : AMITIZA

    Patent Number : 2464420

    Filing Date : 2002-11-14

    Strength per Unit : 24 mcg

    Dosage Form : CAPSULE

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2022-11-14

    Date Granted : 2011-12-13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Kirby Eades Gale Baker

    LUBIPROSTONE
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Kirby Eades Gale Baker

    Country
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Patent Expiration Date : 2027-01-23

    Date Granted : 2013-06-04

    LUBIPROSTONE

    Brand Name : AMITIZA

    Patent Number : 2637274

    Filing Date : 2007-01-23

    Strength per Unit : 24 mcg

    Dosage Form : CAPSULE

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2027-01-23

    Date Granted : 2013-06-04

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.